-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 NwToI84i8W+Ae+/dxBsDgw4ZUzk8PVs2AJ0s+JlzdIgHPwi28qVP7s1x7fU8z+0M
 4I4gI2BQZngXRTN1UGpeHA==

<SEC-DOCUMENT>0001082504-07-000035.txt : 20070608
<SEC-HEADER>0001082504-07-000035.hdr.sgml : 20070608
<ACCEPTANCE-DATETIME>20070608105915
ACCESSION NUMBER:		0001082504-07-000035
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20070605
FILED AS OF DATE:		20070608
DATE AS OF CHANGE:		20070608

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PAR PHARMACEUTICAL COMPANIES, INC.
		CENTRAL INDEX KEY:			0000878088
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				223122182
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0930

	BUSINESS ADDRESS:	
		STREET 1:		300 TICE BOULEVARD
		CITY:			WOODCLIFF LAKE
		STATE:			NJ
		ZIP:			07677
		BUSINESS PHONE:		845-425-7100

	MAIL ADDRESS:	
		STREET 1:		300 TICE BOULEVARD
		CITY:			WOODCLIFF LAKE
		STATE:			NJ
		ZIP:			07677

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	PHARMACEUTICAL RESOURCES INC
		DATE OF NAME CHANGE:	19940526

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			LUBATKIN VERONICA
		CENTRAL INDEX KEY:			0001402404

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-10827
		FILM NUMBER:		07908564

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		201-802-4000

	MAIL ADDRESS:	
		STREET 1:		C/O PAR PHARMACEUTICAL COMPANIES, INC.
		STREET 2:		300 TICE BOULEVARD
		CITY:			WOODCLIFF LAKE
		STATE:			NJ
		ZIP:			07677
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>primary_doc.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0202</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2007-06-05</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0000878088</issuerCik>
        <issuerName>PAR PHARMACEUTICAL COMPANIES, INC.</issuerName>
        <issuerTradingSymbol>PRX</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001402404</rptOwnerCik>
            <rptOwnerName>LUBATKIN VERONICA</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O PAR PHARMACEUTICAL COMPANIES, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>300 TICE BOULEVARD</rptOwnerStreet2>
            <rptOwnerCity>WOODCLIFF LAKE</rptOwnerCity>
            <rptOwnerState>NJ</rptOwnerState>
            <rptOwnerZipCode>07677</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>Executive Vice Pres &amp; CFO</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Restricted Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>23000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Common Stock, Option to Buy</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>27.55</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F1"/>
            </exerciseDate>
            <expirationDate>
                <value>2016-04-19</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>15000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Common Stock, Option to Buy</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>24.27</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <value>2017-03-22</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>7100</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
        <derivativeHolding>
            <securityTitle>
                <value>Restricted Stock Units</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>0</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <footnoteId id="F3"/>
            </exerciseDate>
            <expirationDate>
                <value>2010-12-20</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>16200</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">3,750 options are currently exercisable; an additional 3,750 options become exercisable on 4/19/08; an additional 3,750 options become exercisable on 4/19/09; and the remaining 3,750 options become exercisable on 4/19/10.</footnote>
        <footnote id="F2">1,775 options become exercisable on 3/22/08; an additional 1,775 options become exercisable on 3/22/09; an additional 1,775 options become exercisable on 3/22/10; and the remaining 1,775 options become exercisable on 3/22/11.</footnote>
        <footnote id="F3">Each stock unit is the economic equivalent of one share of common stock; 25% vest on the first anniversary of the date of grant (12/20/07) and an additional 25% vest on each anniversary thereafter until fully vested and distributed on 12/20/10.  The closing price of the Company's Common Stock as reported by The New York Stock Exchange, Inc. on the date of grant was $21.68.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Veronica Lubatkin</signatureName>
        <signatureDate>2007-06-07</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----